-
2024-512084-31-00
6
2025-06-24
Patients requiring emergency abdominal or body CT with eGFR 15-45 ml/m
-
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)
-
2023-508196-36-00
4
2025-05-27
Follicular lymphoma
-
2024-517147-31-00
9
2025-05-23
Tumours, Gynecological
-
2024-516615-25-00
1
2025-05-14
hepatocellular carcinoma (HCC)
-
2024-515445-42-00
5
2025-03-24
Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast
-
2024-511652-40-00
5
2025-02-05
METASTATIC CASTRATION RESISTANT PROSTATE CANCER
-
2024-513406-59-00
5
2025-02-05
Inguinal hernia open surgery recovery
-
2024-520288-15-00
6
2025-01-25
Metastatic or locally advanced inoperable colorectal cancer
-
2024-517831-28-00
6
2025-01-01
Incidence of reappearance of the muscle relaxation after reversal with
-
2023-508813-18-00
4
2024-12-18
Refractory Focal Onset Epilepsy
-
2024-513860-25-00
9
2024-12-10
Ovarian Neoplasms
-
2024-512475-12-01
6
2024-11-27
We are investigating the efficacy and safety of enhanced thromboprophy
-
2024-519263-18-00
6
2024-11-26
Participants are pregnant women found to carry Group G or C Streptococ
-
2024-513009-30-00
4
2024-11-21
Moderate to Severe Crohn’s Disease
-
2023-509994-22-00
5
2024-11-15
cutaneous malignant melanoma
-
2024-517478-68-01
4
2024-11-06
Advanced Cancer
-
2024-517508-12-00
6
2024-10-24
Undergoing hysterectomy
-
2022-500596-32-00
4
2024-10-01
Aneyrysmal subarachnoid hemorrhage needing ventilatory care in intensi
-
2023-508811-21-00
10
2024-09-25
Refractory Focal Onset Epilepsy
-
2023-507353-15-00
5
2024-09-10
idiopathic pulmonary fibrosis (IPF)
-
2023-504704-28-00
4
2024-09-01
Prostate cancer
-
2023-510415-19-00
4
2024-08-28
Acute Myeloid Leukemia
-
2023-507486-26-00
1
2024-08-20
Advanced metastatic castration-resistant prostate cancer with prostate